Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer

After cytoreductive nephrectomy, critical care therapy rate was 7.3% vs. in-hospital mortality was 2.4%. Of patients at highest risk of critical care therapy need were those with CCI greater than or equal to 3 and those 71 years old or older. Ideally, these patients should represent targets for thorough assessment of risk factors for complications before cytoreductive nephrectomy.

Authors

Institutions

Publication Details

Journal
Critical Care Medicine
Published
2024-11-14
DOI
https://doi.org/10.1097/ccm.0000000000006496
Citations
2
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.84
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer

Zhe Tian, Luis Kluth, Francesco Di Bello, Carolin Siech et al.
2 citations
Critical Care Medicine
Renal cell carcinoma treatment
0.84
article

Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer

Zhe Tian, Luis Kluth, Francesco Di Bello, Carolin Siech, Alberto Briganti, Nicola Longo, Jordan A. Goyal, Ottavio De Cobelli, Letizia Maria Ippolita Jannello, Fred Saad, Mario de Angelis, Stefano Puliatti, Benedikt Hoeh, Natali Rodriguez Peñaranda, Felix K. H. Chun, Pierre I Karakiewicz, Shahrokh F Shariat, Philipp Mandel
article en
2 citations

Abstract

After cytoreductive nephrectomy, critical care therapy rate was 7.3% vs. in-hospital mortality was 2.4%. Of patients at highest risk of critical care therapy need were those with CCI greater than or equal to 3 and those 71 years old or older. Ideally, these patients should represent targets for thorough assessment of risk factors for complications before cytoreductive nephrectomy.

Critical Care MedicineVol. 53(1)
Al-Ahliyya Amman University (JO), Goethe University Frankfurt (DE), University of Modena and Reggio Emilia (IT), Vita-Salute San Raffaele University (IT), University of Milan (IT), Cornell University (US), Comprehensive Cancer Center Vienna (AT), IRCCS Ospedale San Raffaele (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), European Institute of Oncology (IT), Université de Montréal (CA), University of Naples Federico II (IT), Medical University of Vienna (AT), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Openalex Percentile: Top 22%
Renal cell carcinoma treatment
0.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.